• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索移动应用程序在抑郁症失眠中的作用:系统评价。

Exploring the Role of Mobile Apps for Insomnia in Depression: Systematic Review.

机构信息

Department of Psychiatry, Wan Fang Hospital, Taipei Medical University, Taipei City, Taiwan.

Psychiatric Research Center, Wan Fang Hospital, Taipei Medical University, Taipei City, Taiwan.

出版信息

J Med Internet Res. 2024 Oct 18;26:e51110. doi: 10.2196/51110.

DOI:10.2196/51110
PMID:39423009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11530740/
Abstract

BACKGROUND

The COVID-19 pandemic has profoundly affected mental health, leading to an increased prevalence of depression and insomnia. Currently, artificial intelligence (AI) and deep learning have thoroughly transformed health care-related mobile apps, offered more effective mental health support, and alleviated the psychological stress that may have emerged during the pandemic. Early reviews outlined the use of mobile apps for dealing with depression and insomnia separately. However, there is now an urgent need for a systematic evaluation of mobile apps that address both depression and insomnia to reveal new applications and research gaps.

OBJECTIVE

This study aims to systematically review and evaluate mobile apps targeting depression and insomnia, highlighting their features, effectiveness, and gaps in the current research.

METHODS

We systematically searched PubMed, Scopus, and Web of Science for peer-reviewed journal articles published between 2017 and 2023. The inclusion criteria were studies that (1) focused on mobile apps addressing both depression and insomnia, (2) involved young people or adult participants, and (3) provided data on treatment efficacy. Data extraction was independently conducted by 2 reviewers. Title and abstract screening, as well as full-text screening, were completed in duplicate. Data were extracted by a single reviewer and verified by a second reviewer, and risk of bias assessments were completed accordingly.

RESULTS

Of the initial 383 studies we found, 365 were excluded after title, abstract screening, and removal of duplicates. Eventually, 18 full-text articles met our criteria and underwent full-text screening. The analysis revealed that mobile apps related to depression and insomnia were primarily utilized for early detection, assessment, and screening (n=5 studies); counseling and psychological support (n=3 studies); and cognitive behavioral therapy (CBT; n=10 studies). Among the 10 studies related to depression, our findings showed that chatbots demonstrated significant advantages in improving depression symptoms, a promising development in the field. Additionally, 2 studies evaluated the effectiveness of mobile apps as alternative interventions for depression and sleep, further expanding the potential applications of this technology.

CONCLUSIONS

The integration of AI and deep learning into mobile apps, particularly chatbots, is a promising avenue for personalized mental health support. Through innovative features, such as early detection, assessment, counseling, and CBT, these apps significantly contribute toward improving sleep quality and addressing depression. The reviewed chatbots leveraged advanced technologies, including natural language processing, machine learning, and generative dialog, to provide intelligent and autonomous interactions. Compared with traditional face-to-face therapies, their feasibility, acceptability, and potential efficacy highlight their user-friendly, cost-effective, and accessible nature with the aim of enhancing sleep and mental health outcomes.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ad/11530740/7b53cc1b9388/jmir_v26i1e51110_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ad/11530740/7b53cc1b9388/jmir_v26i1e51110_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ad/11530740/7b53cc1b9388/jmir_v26i1e51110_fig1.jpg
摘要

背景

新冠疫情对心理健康产生了深远影响,导致抑郁和失眠的发病率上升。目前,人工智能(AI)和深度学习彻底改变了与健康相关的移动应用程序,为心理健康提供了更有效的支持,并缓解了疫情期间可能出现的心理压力。早期的综述分别概述了使用移动应用程序治疗抑郁和失眠的情况。然而,现在迫切需要对同时治疗抑郁和失眠的移动应用程序进行系统评估,以揭示新的应用和研究空白。

目的

本研究旨在系统地回顾和评估针对抑郁和失眠的移动应用程序,重点介绍其功能、有效性以及当前研究中的空白。

方法

我们系统地检索了 2017 年至 2023 年期间发表的同行评议期刊文章,包括 PubMed、Scopus 和 Web of Science。纳入标准为:(1)关注同时治疗抑郁和失眠的移动应用程序,(2)涉及年轻人或成年参与者,以及(3)提供治疗效果数据的研究。由 2 名评审员独立进行数据提取。通过重复进行标题和摘要筛选以及全文筛选,完成了研究的选择。由一名评审员提取数据,另一名评审员验证数据,相应地完成偏倚风险评估。

结果

在最初的 383 项研究中,经过标题、摘要筛选和重复项去除后,有 365 项被排除在外。最终,有 18 篇全文文章符合我们的标准,并进行了全文筛选。分析结果显示,与抑郁和失眠相关的移动应用程序主要用于早期检测、评估和筛查(n=5 项研究);咨询和心理支持(n=3 项研究);以及认知行为疗法(CBT;n=10 项研究)。在 10 项与抑郁相关的研究中,我们的发现表明,聊天机器人在改善抑郁症状方面具有显著优势,这是该领域的一项有前途的发展。此外,有 2 项研究评估了将移动应用程序作为抑郁和睡眠替代干预措施的有效性,进一步扩展了这项技术的应用潜力。

结论

将人工智能和深度学习集成到移动应用程序中,特别是聊天机器人,是个性化心理健康支持的有前途的途径。通过创新功能,如早期检测、评估、咨询和 CBT,这些应用程序显著有助于改善睡眠质量和治疗抑郁。综述的聊天机器人利用了自然语言处理、机器学习和生成式对话等先进技术,提供智能和自主交互。与传统的面对面治疗相比,它们的可行性、可接受性和潜在疗效突出了其用户友好、经济高效和可及性,旨在改善睡眠和心理健康结果。

相似文献

1
Exploring the Role of Mobile Apps for Insomnia in Depression: Systematic Review.探索移动应用程序在抑郁症失眠中的作用:系统评价。
J Med Internet Res. 2024 Oct 18;26:e51110. doi: 10.2196/51110.
2
Comparison of self-administered survey questionnaire responses collected using mobile apps versus other methods.使用移动应用程序与其他方法收集的自我管理调查问卷回复的比较。
Cochrane Database Syst Rev. 2015 Jul 27;2015(7):MR000042. doi: 10.1002/14651858.MR000042.pub2.
3
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
4
Smartphone and tablet self management apps for asthma.用于哮喘的智能手机和平板电脑自我管理应用程序。
Cochrane Database Syst Rev. 2013 Nov 27;2013(11):CD010013. doi: 10.1002/14651858.CD010013.pub2.
5
The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review.低强度心理干预在预防抑郁复发中的临床效果和成本效益:系统评价。
Health Technol Assess. 2012 May;16(28):1-130. doi: 10.3310/hta16280.
6
Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition.改善患有慢性病的儿童和青少年的学校参与度和学业成绩的教育支持服务。
Cochrane Database Syst Rev. 2023 Feb 8;2(2):CD011538. doi: 10.1002/14651858.CD011538.pub2.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Conversational AI and Vaccine Communication: Systematic Review of the Evidence.会话式人工智能与疫苗传播:证据的系统评价。
J Med Internet Res. 2023 Oct 3;25:e42758. doi: 10.2196/42758.
9
Group cognitive behavioural therapy for postnatal depression: a systematic review of clinical effectiveness, cost-effectiveness and value of information analyses.产后抑郁的团体认知行为疗法:临床有效性、成本效益和信息价值分析的系统评价。
Health Technol Assess. 2010 Sep;14(44):1-107, iii-iv. doi: 10.3310/hta14440.
10
Mobile Apps to Support Mental Health Response in Natural Disasters: Scoping Review.移动应用程序在自然灾害中支持心理健康反应:范围综述。
J Med Internet Res. 2024 Apr 17;26:e49929. doi: 10.2196/49929.

引用本文的文献

1
Digital therapeutics for insomnia: an umbrella review and meta-meta-analysis.失眠的数字疗法:一项伞状综述和元元分析
NPJ Digit Med. 2025 Aug 28;8(1):554. doi: 10.1038/s41746-025-01946-y.

本文引用的文献

1
Perspective of artificial intelligence in healthcare data management: A journey towards precision medicine.人工智能在医疗保健数据管理中的展望:迈向精准医学的旅程。
Comput Biol Med. 2023 Aug;162:107051. doi: 10.1016/j.compbiomed.2023.107051. Epub 2023 May 30.
2
A chatbot for mental health support: exploring the impact of Emohaa on reducing mental distress in China.一款用于心理健康支持的聊天机器人:探索Emohaa在中国减轻心理困扰方面的影响。
Front Digit Health. 2023 May 4;5:1133987. doi: 10.3389/fdgth.2023.1133987. eCollection 2023.
3
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine.
GPT-4作为医学人工智能聊天机器人的益处、局限性和风险
N Engl J Med. 2023 Mar 30;388(13):1233-1239. doi: 10.1056/NEJMsr2214184.
4
eHealth-Based Psychosocial Interventions for Adults With Insomnia: Systematic Review and Meta-analysis of Randomized Controlled Trials.基于电子健康的失眠症成年患者心理社会干预措施:随机对照试验的系统评价和荟萃分析。
J Med Internet Res. 2023 Mar 14;25:e39250. doi: 10.2196/39250.
5
Chatbots for future docs: exploring medical students' attitudes and knowledge towards artificial intelligence and medical chatbots.未来医生的聊天机器人:探索医学生对人工智能和医疗聊天机器人的态度和知识。
Med Educ Online. 2023 Dec;28(1):2182659. doi: 10.1080/10872981.2023.2182659.
6
Artificial Intelligence-Based Chatbots for Promoting Health Behavioral Changes: Systematic Review.基于人工智能的聊天机器人促进健康行为改变:系统评价。
J Med Internet Res. 2023 Feb 24;25:e40789. doi: 10.2196/40789.
7
The Future of AI in Medicine: A Perspective from a Chatbot.人工智能在医学领域的未来:来自聊天机器人的视角
Ann Biomed Eng. 2023 Feb;51(2):291-295. doi: 10.1007/s10439-022-03121-w. Epub 2022 Dec 26.
8
Chatbot-Delivered Cognitive Behavioral Therapy in Adolescents With Depression and Anxiety During the COVID-19 Pandemic: Feasibility and Acceptability Study.新冠疫情期间针对抑郁和焦虑青少年的聊天机器人认知行为疗法:可行性与可接受性研究
JMIR Form Res. 2022 Nov 22;6(11):e40242. doi: 10.2196/40242.
9
Mental Health Chatbot for Young Adults With Depressive Symptoms During the COVID-19 Pandemic: Single-Blind, Three-Arm Randomized Controlled Trial.新冠疫情期间抑郁症状青年使用心理健康聊天机器人:单盲、三臂随机对照试验。
J Med Internet Res. 2022 Nov 21;24(11):e40719. doi: 10.2196/40719.
10
Current Artificial Intelligence (AI) Techniques, Challenges, and Approaches in Controlling and Fighting COVID-19: A Review.当前人工智能 (AI) 技术在控制和抗击 COVID-19 方面的挑战和方法:综述。
Int J Environ Res Public Health. 2022 May 12;19(10):5901. doi: 10.3390/ijerph19105901.